Kn. Boykin et al., The use of FDG-positron emission tomography for the evaluation of colorectal metastases of the liver, AM SURG, 65(12), 1999, pp. 1183-1185
Each year at least 130,000 people in the United States are diagnosed with c
olorectal carcinoma. Approximately 14,000 of these patients will have liver
metastases, and 20 per cent of these patients will die from these metastas
es. Surgical resection is the only possible chance for cure in patients wit
h only intrahepatic metastases, and extrahepatic disease is a contraindicat
ion to glucose metabolism. Positron emission tomography (PET) allows the in
vivo study of the uptake and use of glucose in human cells. Here, we revie
w our experience with the use of PET imaging for the diagnosis and manageme
nt of colorectal metastases of the liver. We conducted a retrospective char
t review of 14 patients undergoing PET imaging for known or suspected hepat
ic metastases from colorectal carcinoma. Results of CT, magnetic resonance
imaging, and PET images were compared with pathological specimens. CT scan
identified 7 lesions, and PET identified 31 intrahepatic lesions. Of the 6
patients who underwent surgery, CT identified 4 (20%) and PET identified 17
(85%) of the 20 intrahepatic metastases histologically confirmed. The accu
racy (number of lesions) of CT and PET was 20 per cent and 85 per cent, res
pectively. CT scans had a sensitivity (number of patients) of 50 per cent,
and PET had a sensitivity of 100 per cent in patients undergoing surgical r
esection. PET imaging altered the management in 49 per cent of patients. Tw
enty-one per cent of patients had their surgery cancelled due to previously
undiagnosed extrahepatic metastases. Twenty-one per cent of patients had n
egative CT scans and underwent surgery on the basis of their PET images, an
d all had histologically proven disease. One patient avoided a second-look
laparotomy when PET revealed a lesion seen on CT to be false positive. PET
is an ideal imaging modality to detect intra- and extrahepatic metastases f
rom colorectal carcinomas and would aid in the surgical management of these
patients.